![Jason Adair](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Adair
Investor Relations Contact bij
LIQUIDIA CORPORATION
Vermogen: 12 M $ op 31-08-2026
Profiel
Jason Adair is Vice President-Corporate Development & Strategy at Liquidia Technologies, Inc. since 2016.
Mr. Adair is Chief Business Officer & Head-Investor Relations at Liquidia Corp.
since 2016.
Formerly, Mr. Adair was Executive Director-Corporate Development at BioCryst Pharmaceuticals, Inc. from 2011 to 2015.
Mr. Adair also served as Vice President-Corporate Development & Strategy at Liquidia Corp.
Education includes an undergraduate degree from Wake Forest University and an MBA from Tuck School of Business at Dartmouth.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-08-2026 | 174.606 ( 0,2% ) | 12 M $ | 31-08-2026 |
Actieve functies van Jason Adair
| Bedrijven | Functie | Begin |
|---|---|---|
| LIQUIDIA CORPORATION | Investor Relations Contact | - |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Corporate Officer/Principal | 14-01-2016 |
Eerdere bekende functies van Jason Adair
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2015 |
| LIQUIDIA CORPORATION | Investor Relations Contact | - |
Opleiding van Jason Adair
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
51
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
